You just read:

Aspire Health Science Files Supplemental Motion for Expedited Hearing in Lawsuit Against Hemostemix Inc. and Suspends Patient Recruitment for Hemostemix CLI Phase 2 Clinical Trial

News provided by

Aspire Health Science, LLC

Feb 13, 2020, 17:16 ET